Drugs / SJP002
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02924155 | Sep → Nov 2016 | — | Samjin Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03723811 | Nov 2017 → Jun 2018 | dry eye syndrome | Samjin Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SJP002 | “SJP002, Topical administered one drops to each eye” NCT02924155 ↗ |
| Route | Topical | “Topical administered one drops to each eye” NCT02924155 ↗ |